XML 33 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
Derivative Financial Instruments
12 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
10. Derivative Financial Instruments
The Company’s Korean subsidiary from time to time has entered into zero cost collar contracts to hedge the risk of changes in the functional-currency-equivalent cash flows attributable to currency rate changes on U.S. dollar denominated revenues.
Details of derivative contracts as of December 31, 2021 are as follows (
in thousands):
 
Date of transaction
  
Type of derivative
 
  
Total notional amount
 
  
Month of settlement
May 13, 2021
  
 
Zero cost collar   
 
$ 39,000      January 2022 to September 2022
August 13, 2021
  
 
Zero cost collar   
 
$ 48,000      January 2022 to December 2022
Details of derivative contracts as of December 31, 2020 are as follows
(in thousands):
 
Date of transaction
  
Type of derivative
 
  
Total notional amount
 
  
Month of settlement
July 13, 2020
  
 
Zero cost collar
 
   $ 30,000      January 2021 to June 2021
December 15, 2020
  
 
Zero cost collar
 
   $ 30,000      July 2021 to December 2021
December 18, 2020
  
 
Zero cost collar
 
   $ 18,000      March 2021 to June 2021
The zero cost collar contracts qualify as cash flow hedges under ASC 815, “Derivatives and Hedging,” since at both the inception of the contracts and on an ongoing basis, the hedging relationship was and is expected to be highly effective in achieving offsetting cash flows attributable to the hedged risk during the term of the contracts.
The fair values of the Company’s outstanding zero cost collar contracts recorded as assets and liabilities as of December 31, 2021 and 2020 are as follows (in thousands):
 
Derivatives designated as hedging instruments:
 
  
December 31,
 
  
2021
 
  
2020
 
Asset Derivatives:
  
     
  
     
  
     
Zero cost collars
     Other current assets      $ —        $ 2,036  
Liability Derivatives:
                          
Zero cost collars
     Other current liabilities      $ 2,020      $ 195  
Offsetting of derivative liabilities as of December 31, 2021 is as follows (in thousands):
 
As of December 31, 2021
 
Gross amounts of
recognized
liabilities
   
Gross amounts
offset in the
balance sheets
   
Net amounts of
liabilities
presented in the
balance sheets
   
Gross amounts not offset
in the balance sheets
   
Net amount
 
 
Financial
instruments
    
Cash collateral
pledged
 
Liability Derivatives:
                                                
Zero cost collars
  $ 2,020     $ —       $ 2,020     $ —        $ (2,060   $ (40
Offsetting of derivative assets and liabilities as of December 31, 2020 is as follows (in thousands): 

 
As of December 31, 2020
 
Gross amounts of
recognized
assets/liabilities
 
 
Gross amounts
offset in the
balance sheets
 
 
Net amounts of
assets/liabilities
presented in the
balance sheets
 
 
Gross amounts not offset
in the balance sheets
 
  
Net amount
 
 
Financial
instruments
 
  
Cash collateral
pledged
 
Asset Derivatives:
 
 
 
 
  
  
                                                 
Zero cost collars
   $ 2,036      $ —        $ 2,036      $ —        $ —        $ 2,036  
Liability Derivatives:
                                                     
Zero cost collars
   $ 195      $ —        $ 195      $ —        $ —        $ 195  
For derivative instruments that are designated and qualify as cash flow hedges, gains or losses on the derivative aside from components excluded from the assessment of effectiveness are reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative, representing hedge components excluded from the assessment of effectiveness, are recognized in current earnings.
The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the years ended December 31, 2021 and 2020. Net sales of discontinued operations for the year ended December 31, 2020 are included in the below table (in thousands):
 
Derivatives in
ASC 815
Cash Flow
Hedging
Relationships
  
Amount of Gain (Loss)
Recognized in
AOCI on
Derivatives
 
  
Location/Amount of Gain (Loss)
Reclassified from AOCI Into
Statement of Operations
 
  
Location/Amount of Gain
Recognized in
Statement of Operations on
Derivatives
 
 
  
2021
 
 
2020
 
  
 
 
  
2021
 
 
2020
 
  
 
 
  
2021
 
  
2020
 
Zero cost collars
   $ (4,665   $ 1,769        Net sales      $ (819   $ 1,363        Other income, net      $ 123      $ 148  
As of December 31, 2021, the amount expected to be reclassified from accumulated other comprehensive loss into loss within the next twelve months is $1,460 thousand.
The Company set aside cash deposits to the counterparties, Nomura Financial Investment (Korea) Co., Ltd. (“NFIK”), Deutsche Bank AG, Seoul Branch (“DB”) and Standard Chartered Bank Korea Limited (“SC”), as required for the zero cost collar contracts. These cash deposits are recorded as hedge collateral on the consolidated balance sheets. Cash deposits as of December 31, 2021 and 2020 are as follows (in thousands):
 
    
December 31,
 
Counterparties
  
2021
    
2020
 
NFIK
   $ —        $ 3,250  
DB
     —          1,000  
SC
     1,000        1,000  
    
 
 
    
 
 
 
Total
   $ 1,000      $ 5,250  
    
 
 
    
 
 
 
The Company is required to deposit additional cash collateral with NFIK and SC for any exposure in excess of $500 thousand. As of December 31, 2021, $760 thousand and $1,300 thousand of additional cash collateral were required
by
NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet. There was no such cash collateral required as of December 31, 2020.
These zero cost collar contracts may be terminated by the counterparties in a number of circumstances, including if the Company’s borrowing rating falls below
B-/B3
or if the Company’s total cash and cash equivalents is less than $30,000 thousand at the end of a fiscal quarter, unless a waiver is
obtained.